Envoy Medical COCH Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | -262.7%-32.9pp | -229.8%-89.3pp | -140.5%— | —— | |
| Operating margin | -9,240.7%-682pp | -8,558.7%-2,749pp | -5,809.8%— | —— | |
| Net margin | -9,857.3%-615pp | -9,242.2%+227pp | -9,469%— | —— | |
| EBITDA margin | -9,115.4%-634pp | -8,481.8%-2,714pp | -5,767.7%— | —— | |
| Free cash flow margin | -7,626.6%+786pp | -8,412.9%-2,628pp | -5,785.1%— | —— | |
| Returns | |||||
| Return on assets | -236.4%-26.5pp | -210%+343pp | -552.7%-545pp | -7.4%-7.3pp | |
| Efficiency | |||||
| Asset turnover | 0×0.0× | 0×0.0× | 0.1×— | —— | |
| Inventory turnover | 0.5×+0.1× | 0.5×-0.1× | 0.6×— | —— | |
| Liquidity | |||||
| Current ratio | 0.5×-0.6× | 1.2×+0.2× | 1×+0.4× | 0.7×+0.3× | |
| Quick ratio | 0.4×-0.5× | 1×+0.1× | 0.8×+0.7× | 0.1×-0.2× | |
| Cash ratio | 0.3×-0.4× | 0.7×+0.1× | 0.6×+0.5× | 0.1×-0.3× | |
| Leverage | |||||
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×— | —— | |
| Interest coverage | -14×+9.6× | -23.6×— | —— | —— | |
| Per Share | |||||
| Book value per share | -$0.52+47.9% | -$1.00-594% | -$0.14+96.0% | -$3.58-180% | |
| Valuation | |||||
| Market capitalization | $61M+83.5% | $28.95M-18.4% | $35.49M-93.3% | $532.31M+3.0% | |
| Enterprise value | $16.31M-33.2% | $24.41M-23.4% | $31.87M— | —— | |
| Price / sales | 260.7×+111× | 128.7×+16.4× | 112.3×— | —— | |
| EV / sales | 67.7×-40.8× | 108.5×+7.6× | 100.9×— | —— | |
| Free cash flow yield | -96.1%-30.7pp | -65.4%-13.9pp | -51.5%— | —— | |
| Earnings yield | -39.9%+27.5pp | -71.8%+12.5pp | -84.3%-81.3pp | -3%-2.9pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Envoy Medical's profit margins?
- Envoy Medical (COCH) runs a -310.7% gross margin and a -9881.2% operating margin, with a -9875.6% net margin.
- Where do Envoy Medical's ratios come from?
- Every ratio is computed from Envoy Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
